JBIO (JBIO) reported R&D of $36.05M in Q1 2026.

How has JBIO's R&D changed year-over-year?

JBIO's R&D increased by 80.1% year-over-year, from $20.02M to $36.05M.

What is the long-term trend for JBIO's R&D?

Over 4 years (2021 to 2025), JBIO's R&D has grown at a 57.9% compound annual growth rate (CAGR), from $14.99M to $93.12M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

JBIO JBIO R&D

R&D at other companies

Travere Therapeutics, Inc.TVTX

$57.09M+21.8%

Vera TherapeuticsVERA

$86.01M+108%

AnaptysBio, Inc.ANAB

$33.99M-17.5%

Avalo TherapeuticsAVTX

$14.05M+54.0%

Cullinan Therapeutics, Inc.CGEM

$42.12M+1.6%

Vor BiopharmaVOR

$17.6M-34.1%

Segments

By segment

See full

JADE101$15.42M+57.9%

JADE201$2.88M-44.2%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's R&D?: JBIO (JBIO) reported R&D of $36.05M in Q1 2026.
How has JBIO's R&D changed year-over-year?: JBIO's R&D increased by 80.1% year-over-year, from $20.02M to $36.05M.
What is the long-term trend for JBIO's R&D?: Over 4 years (2021 to 2025), JBIO's R&D has grown at a 57.9% compound annual growth rate (CAGR), from $14.99M to $93.12M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.